Effect of the NSAID nimesulide on the radical scavenger glutathione S‑transferase in patients with osteoarthritis of the knee

References

• Wieland HA, Michaelis M, Kirschbaum BJ, Rudolphi KA. Osteoarthritis – an untreatable disease? Nature Rev Drug Discov 2005;4:331–44
   PubMed Web of Science ®Google Scholar
• Kean WF, Kean, R, Buchanan WW. Osteoarthritis: symptoms, signs and source of pain. Inflammopharmacology 2004;12:3–31
   PubMedGoogle Scholar
• Felson DT. The sources of pain in knee osteoarthritis. Curr Opin Rheumatol 2005;17:624–8
   PubMed Web of Science ®Google Scholar
• WHO Scientific Group. The burden of musculoskeletal conditions at the start of the new millennium. World Health Organ Tech Rep Ser 2003;919:1–218
   Web of Science ®Google Scholar
• Pavelka K. Symptomatic treatment of osteoarthritis: paracetamol or NSAIDs? Int J Clin Pract 2004;58:5–12
   Web of Science ®Google Scholar
• Jordan KM, Arden NK, Doherty M, et al. EULAR Recommendations 2003; an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 2003;62:1145–55
   PubMed Web of Science ®Google Scholar
• Davis R, Brogden RN. Nimesulide – an update of its pharmaco-dynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs 1994;48:431–54
   PubMed Web of Science ®Google Scholar
• Bennett A. Nimesulide: a well-established cyclooxygenase-2 inhibitor with many other pharmacological properties relevant to inflammatory diseases. In: Vane JJ, Botting RM eds. Therapeutic Roles of Selective COX-2 Inhibitors. London: William Harvey Press, 2001:524–40
   Google Scholar
• Rainsford KD. The discovery, development and novel actions of nimesulide. In: Rainsford KD, ed. Nimesulide, Actions and Uses. Basel, Boston, Berlin: Birkhäuser Verlag, 2005
   Google Scholar
• Rainsford KD; Members of the Consensus Report Group on Nimesulide. Nimesulide – a multifactorial approach to inflammation and pain: scientific and clinical consensus. Curr Med Res Opin 2006;22:1161–70
   Google Scholar
• Ostalowska A, Birkner E, Wiecha M, et al. Lipid peroxidation and antioxidant enzymes in synovial fluid of patients with primary and secondary osteoarthritis of the knee joint. Osteoarthr Cartil 2006;14:139–45
   PubMed Web of Science ®Google Scholar
• Zheng SX, Monithys-Mickalad A, et al. In vitro study of the antioxidant properties of nimesulide and 4-OH nimesulide: effects on HRP- and luminal dependent chemoluminescence produced by human chondrocytes. Osteoarthri Cartil 2000;8:419–25
   PubMed Web of Science ®Google Scholar
• Yudoh K, Nguyen T, Nakamura H, et al. Potential involvement of oxidative stress in cartilage senescence and development of osteoarthritis: oxidative stress induces chondrocyte telomere instability and down regulation of chondrocyte function. Arthritis Res Ther 2005;7:R380–91. Epub 2005 Jan 26
   Google Scholar
• Kidd PM. Glutathione: systemic protectant against oxidative and free radical damage. Alt Med Rev 1997;2:155–76
   Google Scholar
• Maffei Facino R, Carini M, Aldini G, et al. Differential inhibition of superoxide, hydroxyl and peroxyl radicals by nimesulide and its main metabolite 4-hydroxynimesulide. Arzneimittelforschung 1995;45:1102–10
   PubMed Web of Science ®Google Scholar
• Bevilacqua M, Vago T, Baldi G, et al. Nimesulide decreases superoxide production by inhibiting phosphodiesterase type IV. Eur J Pharmacology, 1994,268:415–23
   PubMed Web of Science ®Google Scholar
• Bevilacqua M, Devogelaer JP, Righini V, et al. Effect of nimesulide on the serum levels of hyaluronan and stromelysin-1 in patients with osteoarthritis: a pilot study. Int J Clin Pract Suppl 2004;144:13–19
   PubMedGoogle Scholar
• Stucki G, Meier D, Stucki S, et al. Evaluation of a German version of WOMAC (Western Ontario und McMaster Universities) Arthrosis Index. Z Rheumatol 1996;55:40–9 [German]
   Google Scholar
• Maffei-Facino R, Carini M, Aldini G. Anti-oxidant activity of nimesulide and its main metabolites. Drugs 1993;46(Suppl 1): 15–21
   Google Scholar
• Ottonello L, Dapino P, Pastorino G, et al. Nimesulide as a down-regulator of the activity of neutrophil myeloperoxidase pathway. Drugs 1993;46:29–33
   PubMedGoogle Scholar
• de Mello SB, Laurindo IM, Cossermelli W. Action of the 4-nitro-2-phenoximethanesulphonamide (nimesulide) on neutrophil chemotaxis and superoxide production. Sao Paulo Med J 1994;112: 489–94
   Google Scholar
• Ottonello L, Dapino P, Scirocco MC, et al. Sulfonamides as anti-inflammatory agents: old drugs for new therapeutic strategies in inflammation? Clin Sci 1995; 88:331–6
   PubMed Web of Science ®Google Scholar
• Su F, Hu X, Jia W, et al. Glutathion S transferase pi indicates chemotherapy resistance in breast cancer. J Surg Res 2003;113:102–8
   PubMed Web of Science ®Google Scholar
• Kullich WC, Niksic F, Klein G. Effect of nimesulide on metalloproteinases and matrix degradation in osteoarthritis: a pilot study. Int J Clin Suppl 2002;128:24–9
   Google Scholar
• Manicourt DH, Bevilacqua M, Righini V, et al. Comparative effect of nimesulide and ibuprofen on the urinary levels of collagen type II C-Telopeptide degradation products and on the serum levels of hyaluronan and matrix metalloproteinases-3 and -13 in patients with flare-up of osteoarthritis. Drugs R D 2005;6:261–71
   PubMedGoogle Scholar
• Sandy JD. Proteolytic degradation of normal and osteoarthritic cartilage. In: Brandt KD, Doherty M, Lohmander LS, eds. Osteoarthritis, 2nd edn. Oxford: Oxford University Press, 2003:82–92
   Google Scholar
• Clark IM, Murphy G. Matrix Proteinases. In: Seibel MJ, Robins SP, Bilezikian JP, eds. Dynamics of Bone and Cartilage Metabolism. San Diego: Academic Press, 1999:137–50
   Google Scholar
• Cawston TE. Metalloproteinase inhibitors and the prevention of connective tissue breakdown. Pharmacol Ther 1996;3:163–82
   Google Scholar
• Brew K, Dinarkarpandian D, Nagase H. Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta 2000;1477:267–83
   PubMed Web of Science ®Google Scholar
• Dean DD, Martel-Pelletier J, Pelletier JP, et al. Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage. J Clin Invest 1989;84:678–85
   PubMed Web of Science ®Google Scholar
• Dawson T, Roman D. Tissue destruction and repair. In: Hochberg MC, Silman AJ, Smolen JS, et al. Rheumatology, 3rd edn. Mosby Verlag, 2003
   Google Scholar